Statistically Speaking – Why a Hybrid of Centralised

Apr 15, 2016

Statistical Monitoring and Key Risk Indicators could be the Answer for Risk-based Monitoring The industry is at a crossroads when it comes to data-driven monitoring practices in clinical trials. While traditional approaches still dominate, new methodologies are increasingly implemented that ...

Read More

Accelerating the Pace of Study Start-up

Apr 15, 2016

Launching a new clinical study is an exciting stage of product development. There is tremendous hope that a new drug will cure illness or bring relief to patients. Inspired, the team jumps in with a sense of urgency – but ...

Read More